North America Neurorehabilitation Devices Market to 2031 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Neurorehabilitation Devices Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Neurorehabilitation Devices Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Neurological Diseases
5.1.2 Growing Number of Clinical Studies on Neurorehabilitation Devices

5.2 Market Opportunities

5.2.1 Strategic Initiatives by Market Players

5.3 Future Trends

5.3.1 Technological Advancements

5.4 Impact of Drivers and Restraints

6. North America Neurorehabilitation Devices Market Regional Analysis

6.1 North America Neurorehabilitation Devices Market Overview

6.2 North America Neurorehabilitation Devices Market Revenue 2021-2031 (US$ Million)

6.3 North America Neurorehabilitation Devices Market Forecast Analysis

7. North America Neurorehabilitation Devices Market Analysis – by Product Type

7.1 Neurorobotic System

7.1.1 Overview
7.1.2 Neurorobotic System: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Brain Computer Interface

7.2.1 Overview
7.2.2 Brain Computer Interface: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Non-invasive Stimulators

7.3.1 Overview
7.3.2 Non-invasive Stimulators: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Wearable Devices

7.4.1 Overview
7.4.2 Wearable Devices: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Neurorehabilitation Devices Market Analysis – by Application

8.1 Stroke

8.1.1 Overview
8.1.2 Stroke: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Traumatic Brain Injury

8.2.1 Overview
8.2.2 Traumatic Brain Injury: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Spinal Cord Injury

8.3.1 Overview
8.3.2 Spinal Cord Injury: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

8.4 Parkinson\'s Disease

8.4.1 Overview
8.4.2 Parkinson\'s Disease: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

8.5 Cerebral Palsy

8.5.1 Overview
8.5.2 Cerebral Palsy: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

9. North America Neurorehabilitation Devices Market Analysis – by End User

9.1 Rehabilitation Centers

9.1.1 Overview
9.1.2 Cerebral Palsy: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Hospitals and Clinics

9.2.1 Overview
9.2.2 Cerebral Palsy: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Home Care

9.3.1 Overview
9.3.2 Cerebral Palsy: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10. North America Neurorehabilitation Devices Market – North America Analysis

10.1 North America

10.1.1 North America Neurorehabilitation Devices Market Breakdown, by Key Country, 2024 and 2031 (%)
10.1.1.1 North America Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 US: North America Neurorehabilitation Devices Market Breakdown, by Product Type
10.1.1.1.2 US: North America Neurorehabilitation Devices Market Breakdown, by Application
10.1.1.1.3 US: North America Neurorehabilitation Devices Market Breakdown, by End User

10.1.1.2 Canada: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 Canada: North America Neurorehabilitation Devices Market Breakdown, by Product Type
10.1.1.2.2 Canada: North America Neurorehabilitation Devices Market Breakdown, by Application
10.1.1.2.3 Canada: North America Neurorehabilitation Devices Market Breakdown, by End User

10.1.1.3 Mexico: North America Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 Mexico: North America Neurorehabilitation Devices Market Breakdown, by Product Type
10.1.1.3.2 Mexico: North America Neurorehabilitation Devices Market Breakdown, by Application
10.1.1.3.3 Mexico: North America Neurorehabilitation Devices Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Neurorehabilitation Devices Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BIONIK

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 BioXtreme Ltd

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Blackrock Microsystems Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Ekso Bionics Holdings Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 EMOTIV

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Hocoma AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Medtronic Plc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Renishaw Plc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Tyromotion GmbH

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights